Deborah Elstein

763 total citations
31 papers, 477 citations indexed

About

Deborah Elstein is a scholar working on Physiology, Cell Biology and Molecular Biology. According to data from OpenAlex, Deborah Elstein has authored 31 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 12 papers in Cell Biology and 10 papers in Molecular Biology. Recurrent topics in Deborah Elstein's work include Lysosomal Storage Disorders Research (27 papers), Cellular transport and secretion (11 papers) and Trypanosoma species research and implications (10 papers). Deborah Elstein is often cited by papers focused on Lysosomal Storage Disorders Research (27 papers), Cellular transport and secretion (11 papers) and Trypanosoma species research and implications (10 papers). Deborah Elstein collaborates with scholars based in Israel, United States and United Kingdom. Deborah Elstein's co-authors include Ari Zimran, Ari Zimran, Gregory M. Pastores, Martin Hřebı́ček, Ayala Abrahamov, Irith Hadas‐Halpern, Ida Vanessa Döederlein Schwartz, Nadia Belmatoug, Patrick Deegan and Joseph Azuri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Hepatology.

In The Last Decade

Deborah Elstein

31 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Elstein Israel 12 412 203 159 148 140 31 477
Ayala Abrahamov Israel 12 398 1.0× 183 0.9× 210 1.3× 169 1.1× 110 0.8× 22 504
Marta Dragosky Argentina 9 415 1.0× 171 0.8× 196 1.2× 167 1.1× 191 1.4× 23 499
Ya. V. Voznyi Russia 12 592 1.4× 171 0.8× 248 1.6× 206 1.4× 140 1.0× 19 685
Mercedes Roca‐Espiau Spain 5 263 0.6× 116 0.6× 116 0.7× 82 0.6× 52 0.4× 10 293
Sabrina Eichler Germany 10 251 0.6× 87 0.4× 94 0.6× 111 0.8× 77 0.6× 15 324
Kristiane Michelin‐Tirelli Brazil 11 288 0.7× 88 0.4× 123 0.8× 98 0.7× 83 0.6× 23 347
Mici Phillips Israel 8 321 0.8× 144 0.7× 139 0.9× 116 0.8× 128 0.9× 14 346
Minke H. de Ru Netherlands 7 334 0.8× 72 0.4× 159 1.0× 48 0.3× 87 0.6× 9 408
Laurie Bailey United States 9 304 0.7× 136 0.7× 110 0.7× 79 0.5× 91 0.7× 20 346
Eugen Mengel United States 9 430 1.0× 61 0.3× 132 0.8× 144 1.0× 49 0.3× 21 482

Countries citing papers authored by Deborah Elstein

Since Specialization
Citations

This map shows the geographic impact of Deborah Elstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Elstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Elstein more than expected).

Fields of papers citing papers by Deborah Elstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Elstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Elstein. The network helps show where Deborah Elstein may publish in the future.

Co-authorship network of co-authors of Deborah Elstein

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Elstein. A scholar is included among the top collaborators of Deborah Elstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Elstein. Deborah Elstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elstein, Deborah, Nadia Belmatoug, Bruno Bembi, et al.. (2024). Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry. Journal of Clinical Medicine. 13(12). 3588–3588. 2 indexed citations
2.
Collin-Histed, Tanya, Kathleen Beusterien, Deborah Elstein, et al.. (2023). A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative. Orphanet Journal of Rare Diseases. 18(1). 195–195. 6 indexed citations
3.
Liévin, Valentin, et al.. (2023). FindZebra online search delving into rare disease case reports using natural language processing. SHILAP Revista de lepidopterología. 2(6). e0000269–e0000269. 4 indexed citations
4.
Elstein, Deborah, Nadia Belmatoug, Patrick Deegan, et al.. (2022). Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials. Orphanet Journal of Rare Diseases. 17(1). 9–9. 12 indexed citations
5.
6.
7.
Elstein, Deborah, Björn Mellgård, Lan Lan, et al.. (2017). Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials. Molecular Genetics and Metabolism. 122(1-2). 113–120. 37 indexed citations
8.
Mehta, Atul, Nadia Belmatoug, Bruno Bembi, et al.. (2017). Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians. Molecular Genetics and Metabolism. 122(3). 122–129. 52 indexed citations
9.
Dussen, Laura van, Ari Zimran, Erik M. Akkerman, et al.. (2012). Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. Blood Cells Molecules and Diseases. 50(3). 206–211. 31 indexed citations
10.
Elstein, Deborah & Ari Zimran. (2011). Recent Advances in Treatment Approaches to Gaucher Disease. Current Pharmaceutical Biotechnology. 12(6). 854–860. 6 indexed citations
11.
Lavi, Ron, Glen M. Doniger, Ely S. Simon, et al.. (2007). The effect of hormone replacement therapy on cognitive function in post-menopausal women. QJM. 100(9). 567–573. 5 indexed citations
12.
Elstein, Deborah, et al.. (2006). National health budgets for expensive orphan drugs: Gaucher disease in Israel as a model. Blood Cells Molecules and Diseases. 37(1). 46–49. 11 indexed citations
13.
Brautbar, Ariel, et al.. (2005). Fibromyalgia and Gaucher's disease. QJM. 99(2). 103–107. 5 indexed citations
14.
Patlas, Michael N., Irith Hadas‐Halpern, Ayala Abrahamov, Ari Zimran, & Deborah Elstein. (2002). Repeat abdominal ultrasound evaluation of 100 patients with type I Gaucher disease treated with enzyme replacement therapy for up to 7 years. The Hematology Journal. 3(1). 17–20. 15 indexed citations
15.
Zimran, Ari, et al.. (2001). Autohemotherapy with ozone for patients with Gaucher disease and severe skeletal involvement. The Pain Clinic. 13(3). 223–226. 1 indexed citations
16.
Wollstein, Gadi, et al.. (1999). PRERETINAL WHITE DOTS IN ADULT-TYPE GAUCHER DISEASE. Retina. 19(6). 570–570. 12 indexed citations
17.
Azuri, Joseph, Deborah Elstein, Amnon Lahad, et al.. (1998). Asymptomatic Gaucher Disease Implications for Large-Scale Screening. Genetic Testing. 2(4). 297–299. 41 indexed citations
18.
Butler, Peter C., et al.. (1997). Effect of macrophage-targeted glucocerebrosidase(alglucerase) on hypolipidaemia of type 1 Gaucher disease(GD). Hepatology. 26. 1015–1015. 1 indexed citations
19.
Elstein, Deborah, et al.. (1994). The selective advantage of Gaucher's disease: TB or not TB?. PubMed. 30(12). 911–2. 7 indexed citations
20.
Elstein, Deborah. (1966). Treatment of rheumatoid arthritis. Chemical and surgical synovectomy.. PubMed. 49(12). 1841–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayala Abrahamov Breakdown of academic impact, for papers by Marta Dragosky Breakdown of academic impact, for papers by Ya. V. Voznyi Breakdown of academic impact, for papers by Mercedes Roca‐Espiau Breakdown of academic impact, for papers by Sabrina Eichler Breakdown of academic impact, for papers by Kristiane Michelin‐Tirelli Breakdown of academic impact, for papers by Mici Phillips Breakdown of academic impact, for papers by Minke H. de Ru Breakdown of academic impact, for papers by Laurie Bailey Breakdown of academic impact, for papers by Eugen Mengel
Rankless by CCL
2026